Status:

COMPLETED

Fatty Acid Oxidation Disorders & Body Weight Regulation Grant

Lead Sponsor:

Oregon Health and Science University

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Oregon State University

Conditions:

Trifunctional Protein Deficiency

Eligibility:

All Genders

7-40 years

Brief Summary

Several hormones involved in body weight regulation increase the subject's ability to burn fat for energy. The purpose of this study is to investigate how burning fat for energy may affect those hormo...

Detailed Description

A role for mitochondrial fatty acid oxidation in the peripheral signaling cascade of leptin, adiponectin and insulin has recently been proposed from animal studies but has not been investigated in hum...

Eligibility Criteria

Inclusion

  • confirmed diagnosis of TFP, LCHAD, CPT2 or VLCAD deficiency
  • at least 7 years of age
  • willingness to complete overnight admission
  • generally healthy

Exclusion

  • inclusion in another research project that alters macronutrient intake
  • diabetes, thyroid disease or other endocrine dysfunction that alters body composition.
  • pregnancy
  • anemia

Key Trial Info

Start Date :

April 1 2006

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2011

Estimated Enrollment :

26 Patients enrolled

Trial Details

Trial ID

NCT00654004

Start Date

April 1 2006

End Date

January 1 2011

Last Update

April 22 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Oregon Health & Science University

Portland, Oregon, United States, 97239